Compared to the healthy controls, patients with obesity and newly diagnosed patients with T2DM with obesity exhibited an increasing trend in C3 and α2-MG levels and a decreasing trend in AAT and ZAG levels. This evidence concerns the gene SERPINA1 and type 2 diabetes mellitus.